Association between prior alcohol use disorders and decreased prefrontal gray matter volumes in bipolar I disorder patients

Carregando...
Imagem de Miniatura
Citações na Scopus
17
Tipo de produção
article
Data de publicação
2011
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER IRELAND LTD
Autores
MATSUO, Koji
NICOLETTI, Mark A.
MONKUL, E. Serap
ZUNTA-SOARES, Giovana B.
HATCH, John P.
SOARES, Jair C.
Citação
NEUROSCIENCE LETTERS, v.503, n.2, p.136-140, 2011
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Up to 50% of bipolar disorder (BD) patients present a lifetime diagnosis of alcohol use disorders (AUD). BD patients with comorbid AUD, even when in remission from the AUD, have a poorer outcome and functional impairment than patients with BD alone. The neurobiological abnormalities that potentially characterize this severe subgroup of BD patients are unknown. Our goal was to investigate gray matter (GM) volume abnormalities in BD I patients with comorbid AUD. Twenty-one BD-AUD patients, 21 BD-nonAUD BD patients, and 25 healthy controls (HC), matched by age, gender, and handedness were studied. The BD-AUD patients were in remission from AUD on average for 6.8 years. 3D SPGR MRIs (TR = 25 ms, TE = 5 ms, slice thickness = 1.5 mm) were acquired from all subjects using a 1.5 T GE Signa Imaging System. We used an optimized voxel-based morphometry protocol to compare GM volumes among the groups. BD-AUD patients presented smaller GM volumes in the left medial frontal and the right anterior cingulate gyri compared to BD-nonAUD patients. BDnon-AUD patients did not present GM volume differences compared to HC. These findings provide evidence for an effect of comorbid AUD on regional brain structure of BD I patients and warrant further research on neurobiological aspects of this prevalent and severe comorbidity.
Palavras-chave
Bipolar disorder, Alcoholism, Comorbidity, Physiopathology, Cerebral cortex, Magnetic resonance imaging
Referências
  1. Nery FG, 2010, J PSYCHIATR RES, V44, P278, DOI 10.1016/j.jpsychires.2009.09.006
  2. Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1
  3. Cardoso BM, 2008, ALCOHOL, V42, P451, DOI 10.1016/j.alcohol.2008.05.003
  4. Tanabe J, 2009, BIOL PSYCHIAT, V65, P160, DOI 10.1016/j.biopsych.2008.07.030
  5. Rosenbloom M, 2003, ALCOHOL RES HEALTH, V27, P146
  6. Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110
  7. Soares JC, 2003, INT J NEUROPSYCHOPH, V6, P171, DOI 10.1017/S1461145703003390
  8. Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008
  9. Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978
  10. Phillips ML, 2008, AM J PSYCHIAT, V165, P313, DOI 10.1176/appi.ajp.2007.07071066
  11. Quickfall J, 2006, J NEUROPSYCH CLIN N, V18, P318, DOI 10.1176/appi.neuropsych.18.3.318
  12. Block RI, 2000, NEUROREPORT, V11, P491, DOI 10.1097/00001756-200002280-00013
  13. Tost H, 2010, J AFFECT DISORDERS, V120, P54, DOI 10.1016/j.jad.2009.04.009
  14. Bora E, 2010, BIOL PSYCHIAT, V67, P1097, DOI 10.1016/j.biopsych.2010.01.020
  15. Benegal V, 2007, ADDICT BIOL, V12, P122, DOI 10.1111/j.1369-1600.2006.00043.x
  16. Abernathy K, 2010, INT REV NEUROBIOL, V91, P289, DOI 10.1016/S0074-7742(10)91009-X
  17. Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786
  18. Fein G, 2002, DRUG ALCOHOL DEPEN, V68, P87, DOI 10.1016/S0376-8716(02)00110-2
  19. YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429
  20. McElroy SL, 2001, AM J PSYCHIAT, V158, P420, DOI 10.1176/appi.ajp.158.3.420
  21. Kempton MJ, 2008, ARCH GEN PSYCHIAT, V65, P1017, DOI 10.1001/archpsyc.65.9.1017
  22. Stanfield AC, 2009, BIPOLAR DISORD, V11, P135, DOI 10.1111/j.1399-5618.2009.00666.x
  23. First M. B., 2002, STRUCTURED CLIN INTE
  24. Gershon S, 1997, ARCH GEN PSYCHIAT, V54, P16
  25. Hamilton M., 1976, ECDEU ASSESSMENT MAN, P179
  26. Holmes K.H., 2009, BIPOLAR DISORD, V11, P30
  27. Makris M., 2008, BIOL PSYCHIAT, V64, P192
  28. Mann K, 2001, ALCOHOL CLIN EXP RES, V25, p104S
  29. O'Neill J, 2001, ADDICT BIOL, V6, P347, DOI 10.1080/13556210020077073
  30. Pandya D.N., 1985, CEREB CORTEX, V2, P3
  31. REGIER D A, 1990, Journal of the American Medical Association, V264, P2511, DOI 10.1001/jama.264.19.2511
  32. Swann AC, 2005, AM J PSYCHIAT, V162, P1680, DOI 10.1176/appi.ajp.162.9.1680